Learn more about the Artemis II launch delay, what concluded the fuel test, and how NASA plans to move forward with its next ...
NOV will hold a conference call to discuss its fourth quarter 2025 results on February 5, 2026 at 10:00 AM Central Time (11:00 AM Eastern Time). The call will be broadcast simultaneously at ...
Q4 2025 Earnings Call February 6, 2026 8:30 AM ESTCompany ParticipantsRyan Johnsrud - Manager of IR, Corporate Development ...
Proto Labs, Inc. (NYSE:PRLB) Q4 2025 Earnings Call Transcript February 6, 2026 Proto Labs, Inc. beats earnings expectations.
AGCO Corporation (NYSE:AGCO) Q4 2025 Earnings Call Transcript February 5, 2026 AGCO Corporation misses on earnings ...
The Artemis program, effectively a successor to the Apollo missions, aims to return Americans to the moon and lay the ...
NOV Inc. (NYSE: NOV) today reported fourth quarter 2025 revenues of $2.28 billion, a decrease of one percent compared to the fourth quarter of 2024. Net income decreased $238 million, or $0.62 per ...
Atlanta, GA, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp, a global provider of AI-powered trust, identity and security solutions provided an overview of business progress for January 2026. Gareth N.
Q4 2025 Earnings Call February 5, 2026 8:15 AM ESTCompany ParticipantsMaziar Doustdar - President, CEO & Member of ...
Kimball Electronics Balances Auto Weakness With Medical Momentum in Upbeat Earnings Call ...
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Drilling, development and more production were the highlights as Alaska's major oil and gas producers and the new entrant which will soon join them with production on the North Slope provided the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results